$BOMO
bowmo, Inc.

2022 Q3 Form 10-Q Financial Statement

#000157587222000786 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $61.18K $0.00
YoY Change 579.79%
Cost Of Revenue $0.00 $20.89K $27.58K
YoY Change -100.0%
Gross Profit $0.00 $40.29K $61.09K
YoY Change -100.0% 347.67%
Gross Profit Margin 65.85%
Selling, General & Admin $359.3K $317.0K $121.1K
YoY Change 189.04% 112.55% 12.08%
% of Gross Profit 786.77% 198.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $359.3K $317.0K $121.1K
YoY Change 189.05% 205.07% 12.08%
Operating Profit -$359.3K -$276.7K -$60.05K
YoY Change 649.74% 194.65%
Interest Expense $200.3K $38.15K -$94.31K
YoY Change -154.22% 63.06% -88.52%
% of Operating Profit
Other Income/Expense, Net -$200.3K -$10.29K -$6.555K
YoY Change 917.99% -57.81%
Pretax Income -$559.6K -$287.0K -$215.4K
YoY Change 13.36% 142.58% -81.98%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$559.6K -$287.0K -$215.4K
YoY Change 13.36% 142.58% -81.98%
Net Earnings / Revenue -469.09%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$26.34
COMMON SHARES
Basic Shares Outstanding 9.900B 6.731B 18.15M
Diluted Shares Outstanding 18.51B 6.731B 18.15M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.09K $284.8K $2.750K
YoY Change 1545.16%
Cash & Equivalents $95.09K $284.8K $2.750K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables
Total Short-Term Assets $95.09K $284.8K $2.750K
YoY Change 1545.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$2.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $95.09K $284.8K $2.750K
Total Long-Term Assets -$2.00 $0.00 $0.00
Total Assets $95.09K $284.8K $2.750K
YoY Change 1545.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $417.3K $392.3K $326.4K
YoY Change 27.83% 20.18% 0.0%
Accrued Expenses $754.0K $1.184M $1.632M
YoY Change -42.1% -19.25% 13.91%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $362.3K $286.2K $847.1K
YoY Change -67.14% -77.98% -48.45%
Long-Term Debt Due $257.2K $257.2K
YoY Change
Total Short-Term Liabilities $2.954M $3.348M $3.014M
YoY Change -1.36% -10.68% -46.63%
LONG-TERM LIABILITIES
Long-Term Debt $306.8K $306.8K $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $306.8K $306.8K $0.00
YoY Change -219.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.954M $3.348M $3.014M
Total Long-Term Liabilities $306.8K $306.8K $0.00
Total Liabilities $3.261M $3.655M $3.014M
YoY Change 8.89% 4.64% -46.63%
SHAREHOLDERS EQUITY
Retained Earnings -$5.574M -$5.015M
YoY Change
Common Stock $218.4K $156.3K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $773.5K $773.5K
YoY Change
Treasury Stock Shares $2.917K $2.917K
Shareholders Equity -$3.166M -$3.370M -$906.4K
YoY Change
Total Liabilities & Shareholders Equity $95.09K $284.8K $2.750K
YoY Change 1545.12%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$559.6K -$287.0K -$215.4K
YoY Change 13.36% 142.58% -81.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$287.2K -$132.2K -$2.960K
YoY Change 1670.84% 239.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $520.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $520.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 97.50K 419.1K
YoY Change 343.18% 974.62%
NET CHANGE
Cash From Operating Activities -287.2K -132.2K -2.960K
Cash From Investing Activities 0.000 520.0
Cash From Financing Activities 97.50K 419.1K
Net Change In Cash -189.7K 287.4K $0.00
YoY Change -3382.53%
FREE CASH FLOW
Cash From Operating Activities -$287.2K -$132.2K -$2.960K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001381871
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3108
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
257185
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54624
dei Entity Registrant Name
EntityRegistrantName
CRUZANI, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4144571
dei Entity Address Address Line1
EntityAddressAddressLine1
99 Wall Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 891
dei Entity Address City Or Town
EntityAddressCityOrTown
New York City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10005
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
398-0002
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
CZNI
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9899574600
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
284820
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
385
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37638
CY2022Q2 us-gaap Assets
Assets
284820
CY2021Q4 us-gaap Assets
Assets
38023
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
392253
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
65853
CY2022Q2 czni Accrued Expenses Current
AccruedExpensesCurrent
286
CY2021Q4 czni Accrued Expenses Current
AccruedExpensesCurrent
286
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1183742
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18602
CY2022Q2 czni Accrued Officer Compensation
AccruedOfficerCompensation
1069074
CY2021Q4 czni Accrued Officer Compensation
AccruedOfficerCompensation
556394
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
286210
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
84681
CY2022Q2 czni Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
159684
CY2021Q4 czni Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
0
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
110992
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3348434
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
839916
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
306815
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
40401
CY2022Q2 us-gaap Liabilities
Liabilities
3655249
CY2021Q4 us-gaap Liabilities
Liabilities
880317
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 czni Preferred Stock Value1
PreferredStockValue1
33815
CY2021Q4 czni Preferred Stock Value1
PreferredStockValue1
0
CY2022Q2 czni Preferred Stock Value2
PreferredStockValue2
50
CY2021Q4 czni Preferred Stock Value2
PreferredStockValue2
0
CY2022Q2 czni Preferred Stock Value3
PreferredStockValue3
50000
CY2021Q4 czni Preferred Stock Value3
PreferredStockValue3
0
CY2022Q2 czni Preferred Stock Value4
PreferredStockValue4
12
CY2021Q4 czni Preferred Stock Value4
PreferredStockValue4
0
CY2022Q2 czni Temporary Equity Carrying Amount Attributable To Parent Series E
TemporaryEquityCarryingAmountAttributableToParentSeriesE
166331
CY2021Q4 czni Temporary Equity Carrying Amount Attributable To Parent Series E
TemporaryEquityCarryingAmountAttributableToParentSeriesE
0
CY2022Q2 czni Preferred Stock Value6
PreferredStockValue6
0
CY2021Q4 czni Preferred Stock Value6
PreferredStockValue6
0
CY2022Q2 czni Preferred Stock Value7
PreferredStockValue7
1000
CY2021Q4 czni Preferred Stock Value7
PreferredStockValue7
0
CY2022Q2 czni Preferred Stock Value8
PreferredStockValue8
0
CY2021Q4 czni Preferred Stock Value8
PreferredStockValue8
652
CY2022Q2 czni Preferred Stock Value9
PreferredStockValue9
0
CY2021Q4 czni Preferred Stock Value9
PreferredStockValue9
1
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15628974812
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15628974812
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18150000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18150000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
156290
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18150
czni Common Stock Shares Yet To Be Issued
CommonStockSharesYetToBeIssued
2550000
CY2021 czni Common Stock Shares Yet To Be Issued
CommonStockSharesYetToBeIssued
0
CY2022Q2 czni Common Stock Value Yet To Be Issued
CommonStockValueYetToBeIssued
26
CY2021Q4 czni Common Stock Value Yet To Be Issued
CommonStockValueYetToBeIssued
0
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2917
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
773500
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2010091
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3802391
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5014544
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4663488
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3370429
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-842294
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
284820
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38023
CY2022Q2 us-gaap Revenues
Revenues
61181
CY2021Q2 us-gaap Revenues
Revenues
9000
us-gaap Revenues
Revenues
149848
us-gaap Revenues
Revenues
9000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
20891
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Cost Of Revenue
CostOfRevenue
48470
us-gaap Cost Of Revenue
CostOfRevenue
0
CY2022Q2 us-gaap Gross Profit
GrossProfit
40290
CY2021Q2 us-gaap Gross Profit
GrossProfit
9000
us-gaap Gross Profit
GrossProfit
101378
us-gaap Gross Profit
GrossProfit
9000
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
101017
CY2021Q2 us-gaap Salaries And Wages
SalariesAndWages
103267
us-gaap Salaries And Wages
SalariesAndWages
203285
us-gaap Salaries And Wages
SalariesAndWages
204535
CY2022Q2 czni Consulting Expense
ConsultingExpense
46667
CY2021Q2 czni Consulting Expense
ConsultingExpense
0
czni Consulting Expense
ConsultingExpense
46667
czni Consulting Expense
ConsultingExpense
0
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
120718
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
0
us-gaap Professional Fees
ProfessionalFees
130718
us-gaap Professional Fees
ProfessionalFees
0
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48588
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
641
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54915
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1048
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
316990
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
103908
us-gaap Operating Expenses
OperatingExpenses
435585
us-gaap Operating Expenses
OperatingExpenses
205583
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-276700
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-93908
us-gaap Operating Income Loss
OperatingIncomeLoss
-334207
us-gaap Operating Income Loss
OperatingIncomeLoss
-196583
CY2022Q2 us-gaap Interest Expense
InterestExpense
38150
CY2021Q2 us-gaap Interest Expense
InterestExpense
23397
us-gaap Interest Expense
InterestExpense
43160
us-gaap Interest Expense
InterestExpense
58947
CY2022Q2 us-gaap Gain Loss On Condemnation
GainLossOnCondemnation
27856
us-gaap Gain Loss On Condemnation
GainLossOnCondemnation
27856
CY2021Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1002
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1545
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
68
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10294
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24399
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16849
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-58879
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-286994
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118307
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-351056
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-255462
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-286994
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-118307
us-gaap Net Income Loss
NetIncomeLoss
-351056
us-gaap Net Income Loss
NetIncomeLoss
-255462
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6730708291
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6730708291
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18150000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18150000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3392972124
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3392972124
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18150000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18150000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-842294
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-64062
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-906356
CY2022Q2 czni Stock Issued During Period Value Reverse Merger Recapitalization
StockIssuedDuringPeriodValueReverseMergerRecapitalization
-3082418
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
306220
CY2022Q2 czni Stock Issued During Period Value Issued For Extinguishment Of Preferred Stock
StockIssuedDuringPeriodValueIssuedForExtinguishmentOfPreferredStock
599119
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-286994
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3370429
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-576427
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-137155
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-713582
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-713582
us-gaap Profit Loss
ProfitLoss
-351056
us-gaap Profit Loss
ProfitLoss
-255462
czni Convertible Debt Issued For Services
ConvertibleDebtIssuedForServices
-46667
czni Convertible Debt Issued For Services
ConvertibleDebtIssuedForServices
0
czni Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
27856
czni Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
0
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
58481
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
0
czni Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
1545
czni Derivative Gain Loss On Derivative Fair Value
DerivativeGainLossOnDerivativeFairValue
-68
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13748
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
42456
czni Reconciliation Of Debt Balances
ReconciliationOfDebtBalances
10714
czni Reconciliation Of Debt Balances
ReconciliationOfDebtBalances
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37638
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18698
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
16491
czni Increase Decrease In Accrued Officer Compensation
IncreaseDecreaseInAccruedOfficerCompensation
59347
czni Increase Decrease In Accrued Officer Compensation
IncreaseDecreaseInAccruedOfficerCompensation
196630
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3108
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-135182
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
517
czni Proceeds From Loans Payable
ProceedsFromLoansPayable
269100
czni Proceeds From Loans Payable
ProceedsFromLoansPayable
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
419100
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
284435
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
385
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
284820
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
czni Common Stock Issued For Extinguishment Of Preferred Stock
CommonStockIssuedForExtinguishmentOfPreferredStock
374185
czni Common Stock Issued For Extinguishment Of Preferred Stock
CommonStockIssuedForExtinguishmentOfPreferredStock
0
czni Tangible Assets Acquired In Merger
TangibleAssetsAcquiredInMerger
3082419
czni Tangible Assets Acquired In Merger
TangibleAssetsAcquiredInMerger
0
czni Equity Acquired In Merger Net
EquityAcquiredInMergerNet
3063589
czni Equity Acquired In Merger Net
EquityAcquiredInMergerNet
0
czni Debt Discount Associated With Issuance Of Warrants
DebtDiscountAssociatedWithIssuanceOfWarrants
306200
czni Debt Discount Associated With Issuance Of Warrants
DebtDiscountAssociatedWithIssuanceOfWarrants
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
466454
us-gaap Stock Issued1
StockIssued1
1000
us-gaap Stock Issued1
StockIssued1
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-style:italic;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-style:italic;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Concentrations of Credit Risk</div></div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-style:italic;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Concentrations of credit risk</div></div></div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: normal; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><br/></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"/> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents, and accounts receivable. Cash and cash equivalents are held in United States financial institutions. At times such amounts may exceed federally insured limits.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><br/></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"/> <div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022, no customers accounted for more than 10% of accounts receivable. As of December 31, 2021, two customers accounted for more than 10% of accounts receivable, at 80% and 19%, for a total of 99%.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three months ended June 30, 2022, two customers accounted for more than 10% of revenue, at 83% and 11%, for a total of 94%. During the three months ended June 30, 2021, one customer accounted for more than 10% of revenue at 100%.</div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <div style="margin: 0px 0px 0px 0in; text-align: justify; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the six months ended June 30, 2022, four customers accounted for more than 10% of revenue, at 60%, 14%, 14% and 12%, for a total of 100%. During the six months ended June 30, 2021, one customer accounted for more than 10% of revenue at 100%.</div></div>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3.108
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61181
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
149848
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
293096
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
293096
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
110992
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
110992
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
93172
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-68
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
93104
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
110992
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
1545
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-112537
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
472605
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
czni Going Concern
GoingConcern
<div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">NOTE 2 – GOING CONCERN</div></div></div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited interim consolidated condensed financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of the Company on a going-concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished in the ordinary course of business at amounts disclosed in the consolidated financial statements. The Company has incurred recurring losses from operations and has an accumulated deficit of ($5,014,544). The Company’s ability to continue as a going concern depends upon its ability to obtain adequate funding to support its operations through continuing investments of debt and/or equity by qualified investors/creditors, internally generated working capital and monetization of intellectual property assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s development and marketing efforts.</div></div>
CY2022Q2 us-gaap Retained Earnings Appropriated
RetainedEarningsAppropriated
-5014544
CY2022Q2 czni Escrow Deposit Current
EscrowDepositCurrent
517
CY2021Q4 czni Escrow Deposit Current
EscrowDepositCurrent
0
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
18602
czni Accrued Interest Acquired In Merger
AccruedInterestAcquiredInMerger
1197027
czni Accrued Interest On Outstanding Indebtedness
AccruedInterestOnOutstandingIndebtedness
18698
czni Less Accrued Interest Extinguished On Conversions Of Debt
LessAccruedInterestExtinguishedOnConversionsOfDebt
50585
CY2022Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
1183742
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
593681
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
84681
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
307471
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
286210
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
84681
CY2022Q2 us-gaap Other Loans Payable
OtherLoansPayable
564000
CY2021Q4 us-gaap Other Loans Payable
OtherLoansPayable
40400
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
254500
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5994
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6807
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7066
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7336
CY2022Q2 czni Long Term Debt Maturity Repayments Year Five And Thereafter
LongTermDebtMaturityRepaymentsYearFiveAndThereafter
282297
CY2022Q2 us-gaap Other Loans Payable
OtherLoansPayable
564000
czni Schedule Reconciliation Of Put Premium On Stock Settled Deb
ScheduleReconciliationOfPutPremiumOnStockSettledDeb
<div style="margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;;margin-right : auto;;margin-left : 0;margin-right : auto;"><tr><td style="width: 87%; padding: 0px 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Balance at December 31, 2021</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">-</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="width: 87%; padding: 0px 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Add: put premium acquired in Merger</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">230,743</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="width: 87%; padding: 0px 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">Add: Gain on new methodology for accounting for debt conversion features</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">84,681</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="width: 87%; padding: 0px 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Add: put premium on new debt issuances</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 10%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">10,714</div></div></td><td style="width: 1%; padding: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr><tr><td style="width: 87%; padding: 0px 0pt 0.5pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Less: put premium on convertible debt extinguished</div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 1pt solid black;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="border-image: initial; width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom; border-bottom: 1pt solid black;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">(166,457</div></div></td><td style="width: 1%; padding: 0in 0in 0.5pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">)</div></div></td></tr><tr><td style="width: 87%; padding: 0px 0pt 1.25pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Balance at June 30, 2022</div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="width: 1%; padding-top: 0in; padding-right: 0in; padding-left: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); border-bottom: 2.5pt double black; text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div></td><td style="border-image: initial; border-bottom: 2.5pt double black; width: 10%; padding-top: 0in; padding-right: 0in; padding-left: 0in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"><div style="margin: 0px 0in; text-align: right; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">159,681</div></div></td><td style="width: 1%; padding: 0in 0in 1.25pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="margin: 0px 0px 0px 0in; text-align: left; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; white-space: nowrap; text-indent: 0in;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></td></tr></table>
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
czni Put Premium Acquired In Merger
PutPremiumAcquiredInMerger
230743
czni Gain On New Methodology For Accounting For Debt Conversion Feature
GainOnNewMethodologyForAccountingForDebtConversionFeature
84681
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
10714
czni Put Premium On Convertible Debt Extinguished
PutPremiumOnConvertibleDebtExtinguished
166457
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
159681
us-gaap Premiums Earned Net
PremiumsEarnedNet
588156
CY2022Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
159681
CY2022Q2 us-gaap Share Price
SharePrice
0
CY2021Q4 us-gaap Share Price
SharePrice
0.1
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.05
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y7M28D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.83
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0039
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
czni Extinguishment Of Convertible Debt
ExtinguishmentOfConvertibleDebt
7662768291
CY2022Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
7662768291
CY2022Q2 czni Debt Instrument Face Value
DebtInstrumentFaceValue
415600
us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
65753
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
71660
CY2022Q2 czni Total Debt Current
TotalDebtCurrent
553013
CY2021Q4 czni Share Available To Purchase With Stock Warrants Outstanding Number
ShareAvailableToPurchaseWithStockWarrantsOutstandingNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1562500000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.0002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
czni Weighted Average Price Forfeited
WeightedAveragePriceForfeited
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
czni Weighted Average Fair Value Expired
WeightedAverageFairValueExpired
0
CY2022Q2 czni Share Available To Purchase With Stock Warrants Outstanding Number
ShareAvailableToPurchaseWithStockWarrantsOutstandingNumber
1562500000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0002
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1562500000
czni Weighted Average Price Exercisable
WeightedAveragePriceExercisable
0.0001
czni Weighted Average Fair Value Exercisable Outstanding
WeightedAverageFairValueExercisableOutstanding
0.0002
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.0001
czni Number Outstanding In Shares
NumberOutstandingInShares
1562500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P6Y11M1D
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.0001
CY2022Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
19875
CY2021Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
40875
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2019Q3 czni Salary Per Month
SalaryPerMonth
10000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
472000
CY2017Q1 czni Obtained Default Judgment
ObtainedDefaultJudgment
27083.74
czni Amount Of Indebtedness
AmountOfIndebtedness
1600000

Files In Submission

Name View Source Status
0001575872-22-000786-index-headers.html Edgar Link pending
0001575872-22-000786-index.html Edgar Link pending
0001575872-22-000786.txt Edgar Link pending
0001575872-22-000786-xbrl.zip Edgar Link pending
czni-20220630.htm Edgar Link pending
czni-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
czni-20220630_def.xml Edgar Link unprocessable
czni-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
czni-20220630_pre.xml Edgar Link unprocessable
czni-20220630_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
nm011_ex-31.htm Edgar Link pending
nm011_ex-32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
czni-20220630_cal.xml Edgar Link unprocessable